Lakefront Biotherapeutics NV (LKFT)
NASDAQ: LKFT · Real-Time Price · USD
28.32
-0.05 (-0.18%)
At close: Jun 18, 2026, 4:00 PM EDT
28.30
-0.02 (-0.07%)
After-hours: Jun 18, 2026, 4:10 PM EDT

LKFT Cash Flow Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
488.78320.8874.08211.7-217.99-103.23
Depreciation & Amortization
37.6255.88-43.6465.5734.64
Stock-Based Compensation
17.6724-56.7288.5170.73
Other Adjustments
-233.05280.18-170.79-66.6863.88-25.17
Change in Receivables
64.1786.59--39.1168.9879.86
Changes in Inventories
20.0728.85--24.08-34.59-21.17
Changes in Accounts Payable
8.8433.81-31.82-2.08-35.35
Changes in Unearned Revenue
-1,012-1,071-255.51-661.06-383.62-453.72
Changes in Other Operating Activities
103.48199.735.7926.5620.2613.03
Operating Cash Flow
-301.6-257.46-320.03-405.97-500.54-503.83
Capital Expenditures
-8.73-13.7-16.72-18.71-27.39-54.21
Sale of Property, Plant & Equipment
1.70.4602.430.74-
Purchases of Intangible Assets
--0.16-65.39-0.57-9.56-3.67
Purchases of Investments
-3,176-3,465-3,386-3,404-2,729-1,561
Proceeds from Sale of Investments
3,4553,7453,6983,4991,6452,131
Payments for Business Acquisitions
----7-115.27-
Proceeds from Business Divestments
-10.1519.43-8.95--28.7
Other Investing Activities
-8.020.95-3.6--38.16-
Investing Cash Flow
265.57288.81220.671.19-1,246541.24
Issuance of Common Stock
---1.776.73.31
Net Common Stock Issued (Repurchased)
---1.776.73.31
Other Financing Activities
-2.77-3.27-4.92-6.77-8.18-7.19
Financing Cash Flow
-2.77-3.27-4.92-5-1.49-3.88
Effect of Exchange Rate Changes on Cash and Cash Equivalents
-2.46-4.461.78-1.5222.2956.76
Net Cash Flow
-38.8128.09-104.35-339.79-1,74833.54
Free Cash Flow
-310.33-271.16-336.75-424.68-527.93-558.03
FCF Margin
-28.43%-23.26%-106.42%-147.97%-190.33%-198.97%
Free Cash Flow Per Share
-4.71-4.11-5.11-6.45-8.04-8.52
Levered Free Cash Flow
-361.89-445.9-162.36-390.13-579.85-620.02
Unlevered Free Cash Flow
-474.48-490.01-534.85-840.93-491.85-686.36
SEC Filings: 10-K · 10-Q